413 related articles for article (PubMed ID: 21771657)
1. Non-antibacterial tetracyclines modulate mediators of periodontitis and atherosclerotic cardiovascular disease: a mechanistic link between local and systemic inflammation.
Gu Y; Lee HM; Sorsa T; Salminen A; Ryan ME; Slepian MJ; Golub LM
Pharmacol Res; 2011 Dec; 64(6):573-9. PubMed ID: 21771657
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of matrix metalloproteinase-mediated periodontal bone loss in rats: a comparison of 6 chemically modified tetracyclines.
Ramamurthy NS; Rifkin BR; Greenwald RA; Xu JW; Liu Y; Turner G; Golub LM; Vernillo AT
J Periodontol; 2002 Jul; 73(7):726-34. PubMed ID: 12146531
[TBL] [Abstract][Full Text] [Related]
3. Collagenase-2 (MMP-8) as a point-of-care biomarker in periodontitis and cardiovascular diseases. Therapeutic response to non-antimicrobial properties of tetracyclines.
Sorsa T; Tervahartiala T; Leppilahti J; Hernandez M; Gamonal J; Tuomainen AM; Lauhio A; Pussinen PJ; Mäntylä P
Pharmacol Res; 2011 Feb; 63(2):108-13. PubMed ID: 20937384
[TBL] [Abstract][Full Text] [Related]
4. Non-antibacterial tetracycline formulations: host-modulators in the treatment of periodontitis and relevant systemic diseases.
Golub LM; Elburki MS; Walker C; Ryan M; Sorsa T; Tenenbaum H; Goldberg M; Wolff M; Gu Y
Int Dent J; 2016 Jun; 66(3):127-35. PubMed ID: 27009489
[TBL] [Abstract][Full Text] [Related]
5. Subantimicrobial dose doxycycline efficacy as a matrix metalloproteinase inhibitor in chronic periodontitis patients is enhanced when combined with a non-steroidal anti-inflammatory drug.
Lee HM; Ciancio SG; Tüter G; Ryan ME; Komaroff E; Golub LM
J Periodontol; 2004 Mar; 75(3):453-63. PubMed ID: 15088884
[TBL] [Abstract][Full Text] [Related]
6. Clinical applications of non-antimicrobial tetracyclines in dermatology.
Monk E; Shalita A; Siegel DM
Pharmacol Res; 2011 Feb; 63(2):130-45. PubMed ID: 20937386
[TBL] [Abstract][Full Text] [Related]
7. Tetracyclines and chemically modified tetracycline-3 (CMT-3) modulate cytokine secretion by lipopolysaccharide-stimulated whole blood.
Cazalis J; Tanabe S; Gagnon G; Sorsa T; Grenier D
Inflammation; 2009 Apr; 32(2):130-7. PubMed ID: 19238528
[TBL] [Abstract][Full Text] [Related]
8. Host modulation therapy with anti-inflammatory agents.
Preshaw PM
Periodontol 2000; 2018 Feb; 76(1):131-149. PubMed ID: 29193331
[TBL] [Abstract][Full Text] [Related]
9. Introduction and background.
Golub LM
Pharmacol Res; 2011 Feb; 63(2):99-101. PubMed ID: 20937387
[TBL] [Abstract][Full Text] [Related]
10. A novel chemically modified curcumin reduces inflammation-mediated connective tissue breakdown in a rat model of diabetes: periodontal and systemic effects.
Elburki MS; Moore DD; Terezakis NG; Zhang Y; Lee HM; Johnson F; Golub LM
J Periodontal Res; 2017 Apr; 52(2):186-200. PubMed ID: 27038334
[TBL] [Abstract][Full Text] [Related]
11. The non-antibiotic properties of tetracyclines: clinical potential in ophthalmic disease.
Federici TJ
Pharmacol Res; 2011 Dec; 64(6):614-23. PubMed ID: 21843641
[TBL] [Abstract][Full Text] [Related]
12. Adjunctive subantimicrobial dose doxycycline: effect on clinical parameters and gingival crevicular fluid transforming growth factor-beta levels in severe, generalized chronic periodontitis.
Gürkan A; Cinarcik S; Hüseyinov A
J Clin Periodontol; 2005 Mar; 32(3):244-53. PubMed ID: 15766366
[TBL] [Abstract][Full Text] [Related]
13. Clinical studies on the management of periodontal diseases utilizing subantimicrobial dose doxycycline (SDD).
Caton J; Ryan ME
Pharmacol Res; 2011 Feb; 63(2):114-20. PubMed ID: 21182947
[TBL] [Abstract][Full Text] [Related]
14. Chemically modified tetracycline-3 (CMT-3): a novel inhibitor of the serine proteinase, elastase.
Gu Y; Lee HM; Simon SR; Golub LM
Pharmacol Res; 2011 Dec; 64(6):595-601. PubMed ID: 21651982
[TBL] [Abstract][Full Text] [Related]
15. Using tetracyclines to treat osteoporotic/osteopenic bone loss: from the basic science laboratory to the clinic.
Payne JB; Golub LM
Pharmacol Res; 2011 Feb; 63(2):121-9. PubMed ID: 20937388
[TBL] [Abstract][Full Text] [Related]
16. A combination of a chemically modified doxycycline and a bisphosphonate synergistically inhibits endotoxin-induced periodontal breakdown in rats.
Llavaneras A; Ramamurthy NS; Heikkilä P; Teronen O; Salo T; Rifkin BR; Ryan ME; Golub LM; Sorsa T
J Periodontol; 2001 Aug; 72(8):1069-77. PubMed ID: 11525440
[TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinases, tissue inhibitor of matrix metalloproteinase-1, and laminin-5 gamma2 chain immunolocalization in gingival tissue of endotoxin-induced periodontitis in rats: effects of low-dose doxycycline and alendronate.
Buduneli E; Vardar-Sengül S; Buduneli N; Atilla G; Wahlgren J; Sorsa T
J Periodontol; 2007 Jan; 78(1):127-34. PubMed ID: 17199549
[TBL] [Abstract][Full Text] [Related]
18. Tetracycline inhibition and the cellular source of collagenase in gingival crevicular fluid in different periodontal diseases. A review article.
Ingman T; Sorsa T; Suomalainen K; Halinen S; Lindy O; Lauhio A; Saari H; Konttinen YT; Golub LM
J Periodontol; 1993 Feb; 64(2):82-8. PubMed ID: 8433257
[TBL] [Abstract][Full Text] [Related]
19. Effects of scaling and root planing and sub-antimicrobial dose doxycycline on oral and systemic biomarkers of disease in patients with both chronic periodontitis and coronary artery disease.
Tüter G; Kurtiş B; Serdar M; Aykan T; Okyay K; Yücel A; Toyman U; Pinar S; Cemri M; Cengel A; Walker SG; Golub LM
J Clin Periodontol; 2007 Aug; 34(8):673-81. PubMed ID: 17590156
[TBL] [Abstract][Full Text] [Related]
20. A herbal formula containing roots of Salvia miltiorrhiza (Danshen) and Pueraria lobata (Gegen) inhibits inflammatory mediators in LPS-stimulated RAW 264.7 macrophages through inhibition of nuclear factor κB (NFκB) pathway.
Cheung DW; Koon CM; Wat E; Ko CH; Chan JY; Yew DT; Leung PC; Chan WY; Lau CB; Fung KP
J Ethnopharmacol; 2013 Feb; 145(3):776-83. PubMed ID: 23261483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
